Ironwood Pharma (IRWD) Tops Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus
Go back to Ironwood Pharma (IRWD) Tops Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.83 +0.01 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.82 | 52 Week High | $16.89 | |||
| Open | $3.77 | 52 Week Low | $7.35 | |||
| Day High | $3.92 | P/E | N/A | |||
| Day Low | $3.76 | EPS | $-2.35 | |||
| Volume | 1,008,961 | |||||

